Inflammatory Marker Testing Identifies CD74 Expression in Melanoma Tumor Cells, and Its Expression Associates with Favorable Survival for Stage III Melanoma

Title
Inflammatory Marker Testing Identifies CD74 Expression in Melanoma Tumor Cells, and Its Expression Associates with Favorable Survival for Stage III Melanoma
Authors
Keywords
-
Journal
CLINICAL CANCER RESEARCH
Volume 22, Issue 12, Pages 3016-3024
Publisher
American Association for Cancer Research (AACR)
Online
2016-01-19
DOI
10.1158/1078-0432.ccr-15-2226

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search